5 most read GI/endoscopy stories — Dec. 12, 2016

Here are the five most read gastroenterology/endoscopy stories for the week of Dec. 12, 2016.

Advertisement

1. Valeant, Takeda deal crumbles; Valeant to invest in Salix: 6 things to know
Click here

2. Metastatic tumor-destroying vaccine for colon cancer patients to begin phase II trial: 6 key notes
Click here

3. GI societies objects to American Board of Internal Medicine’s certification proposals: 4 notes
Click here

4. How LifeBond is trying to solve a surgeon’s biggest headache
Click here

5. Invendo receives CE Mark for sterile, single-use endoscope: 5 things you need to know
Click here

More articles on gastroenterology/endoscopy:
Dr. Albert Czaja receives Mayo Clinic award & more — 3 GI physicians in the headlines
NCI scientists reverse a woman’s colon cancer with immunotherapy: 5 research insights
GI leader to know: Dr. Kumar Gutta of Gastroenterology Associates of North Texas

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.